In this webinar, the Cell and Gene Therapy Catapult is joined by the MHRA to provide an overview of the UK’s world-leading infrastructure for advanced therapies, including its robust clinical trial network, supportive regulatory frameworks, and market access landscape.
Watch the Webinar
Please provide your details to gain access.
The Cell and Gene Therapy Catapult takes your data very seriously. By using this form you are consenting to the processing of your personal data as per ourprivacy policy.
The session also highlights how the Cell and Gene Therapy Catapult supports international developers in planning clinical trials and facilitating therapy adoption in the UK.
Speakers:
- Andrea Manfrin, Deputy Director, Clinical Investigations and Trials, MHRA
- Jacqueline Barry, Chief Clinical Officer, CGT Catapult (Chair)
- Emily Merrell, Director of ATTC Network Coordination, CGT Catapult
- Jan Mothes, Senior Regulatory Affairs Manager, CGT Catapult
- Laura Beswick, Head of Health Economics and Market Access, CGT Catapult
- Panos Kefalas, Director of Access Strategy, CGT Catapult
- Rehma Chandaria, Regulatory Affairs Lead, CGT Catapult
Who should watch?
We particularly encourage senior leadership teams of therapy developer organisations based in the US, working on all modalities and stages, to view this webinar.